This article is more than 5 years old. Information may no longer be current.

VIDEO: Surgeon presents positive study results of Mydrane ophthalmic solution

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

ATHENS, Greece — At the European Society of Cataract and Refractive Surgeons winter meeting, Béatrice Cochener, MD, PhD, presents results from a study of Mydrane (tropicamide 0.02%, phenylephrine 0.31%, lidocaine 1%, Théa) as a fixed dose given intracamerally before cataract surgery. The study found that the combination of mydriatic and anesthetic provided fast pupil dilation and extra comfort for the patient while avoiding toxic effects of drops on the ocular surface.